Molecular Hemato-Oncology Group

  1. Home
  2. Molecular Hemato-Oncology
  3. Tests
# Test Name Group Category
1 add. analysis BCR-ABL quantitative Molecular Hemato-Oncology Molecular Hemato-Oncology
2 BEI T-LGL, sequencing STAT4 Molecular Hemato-Oncology Molecular Hemato-Oncology
3 CBFβ-MYH11 quantitative A-type Molecular Hemato-Oncology Molecular Hemato-Oncology
4 Clonal T-cell receptor TCR-Beta Molecular Hemato-Oncology Molecular Hemato-Oncology
5 Clonal T-cell receptor TCR-Gamma Molecular Hemato-Oncology Molecular Hemato-Oncology
6 confirmation sequencing after HRM Molecular Hemato-Oncology Molecular Hemato-Oncology
7 detection KIT D816V Molecular Hemato-Oncology Molecular Hemato-Oncology
8 detection t(8:13) Molecular Hemato-Oncology Molecular Hemato-Oncology
9 Fast Test AML FAB M2 M3 M4 Molecular Hemato-Oncology Molecular Hemato-Oncology
10 Follow up BCR-ABL, quant. Molecular Hemato-Oncology Molecular Hemato-Oncology
11 Follow up BCR-ABL, quant. Bonemarrow Molecular Hemato-Oncology Molecular Hemato-Oncology
12 fragment analysis and sequencing ex9 of CALR Molecular Hemato-Oncology Molecular Hemato-Oncology
13 genotyping JAK-2, Exon12 Molecular Hemato-Oncology Molecular Hemato-Oncology
14 IDH2 (Isocitrate dehydrogenase 2) Molecular Hemato-Oncology Molecular Hemato-Oncology
15 IGVH fragment length analysis in suspected B-cell clonality Molecular Hemato-Oncology Molecular Hemato-Oncology
16 inv16 t(16;16) AML FAB M4 (CBFβ-MYH11) Molecular Hemato-Oncology Molecular Hemato-Oncology
17 JAK2 search for mutations Ex.12-15 (HRM) Molecular Hemato-Oncology Molecular Hemato-Oncology
18 JAK2 V617F quantitative PCR Molecular Hemato-Oncology Molecular Hemato-Oncology
19 Mikrodeletion 4q12 (FIP1L1-PDGFRA PCR) Molecular Hemato-Oncology Molecular Hemato-Oncology
20 Minimal residual disease JAK2 V617F Molecular Hemato-Oncology Molecular Hemato-Oncology